171 related articles for article (PubMed ID: 16118027)
1. Is there a customised immunosuppressive regimen for patients transplanted with hepatocellular carcinoma?
Majno P; Giostra E; Mentha G;
J Hepatol; 2005 Oct; 43(4):577-84. PubMed ID: 16118027
[No Abstract] [Full Text] [Related]
2. Early occurrence of hepatocellular carcinoma in biliary atresia treated by liver transplantation.
Brunati A; Feruzi Z; Sokal E; Smets F; Fervaille C; Gosseye S; Clapuyt P; de Ville de Goyet J; Reding R
Pediatr Transplant; 2007 Feb; 11(1):117-9. PubMed ID: 17239135
[TBL] [Abstract][Full Text] [Related]
3. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
[No Abstract] [Full Text] [Related]
4. Steroid-free immunosuppression for pancreas-after-liver transplantation.
Suárez F; Otero A; Quintela J; Aguirrezabalaga J; Gala B; Gómez M
Transplant Proc; 2005 Nov; 37(9):3975-6. PubMed ID: 16386601
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J
Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
[TBL] [Abstract][Full Text] [Related]
6. [Liver transplantation: personalized immunosuppression in patients with hepatitis C virus infection and hepatocellular carcinoma].
Rubín A; Berenguer M
Gastroenterol Hepatol; 2013 Jan; 36(1):48-57. PubMed ID: 22578313
[TBL] [Abstract][Full Text] [Related]
7. [Report on two orthotopic homologous transplantations of the human liver of adults].
Gedigk P; Bechtelsheimer H; Müller R; Lee TS
Verh Dtsch Ges Pathol; 1970; 54():130-6. PubMed ID: 4104518
[No Abstract] [Full Text] [Related]
8. Immunosuppression and hepatocellular carcinoma.
Schlitt HJ; Mornex F; Shaked A; Trotter JF
Liver Transpl; 2011 Oct; 17 Suppl 2():S159-61. PubMed ID: 21506251
[No Abstract] [Full Text] [Related]
9. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
[TBL] [Abstract][Full Text] [Related]
10. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.
Toso C; Meeberg GA; Bigam DL; Oberholzer J; Shapiro AM; Gutfreund K; Ma MM; Mason AL; Wong WW; Bain VG; Kneteman NM
Transplantation; 2007 May; 83(9):1162-8. PubMed ID: 17496530
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for hepatocellular carcinoma.
Heimbach JK
Cancer J; 2008; 14(2):95-9. PubMed ID: 18391614
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation and tacrolimus monotherapy for hepatocellular carcinoma with expanded criteria.
Dalgic A; Karakayali H; Moray G; Emiroglu R; Sozen H; Torgay A; Haberal M
Transplant Proc; 2005 Sep; 37(7):3154-6. PubMed ID: 16213334
[TBL] [Abstract][Full Text] [Related]
14. Recipient-based approach to tailoring immunosuppression in liver transplantation.
Kemmer N; Neff G
Transplant Proc; 2010 Jun; 42(5):1731-7. PubMed ID: 20620512
[TBL] [Abstract][Full Text] [Related]
15. [Liver transplantation].
Otto G; Herfarth C
Dtsch Med Wochenschr; 1991 Apr; 116(15):579-83. PubMed ID: 1849476
[No Abstract] [Full Text] [Related]
16. Liver transplantation for hepatic malignancies in children--we all need more information.
Kaliciński P; Otte JB
Pediatr Transplant; 2009 Sep; 13(6):657-8. PubMed ID: 19691562
[No Abstract] [Full Text] [Related]
17. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
Schwartz M; Roayaie S; Llovet J
J Hepatol; 2005 Oct; 43(4):584-9. PubMed ID: 16120468
[No Abstract] [Full Text] [Related]
18. Current role of surgery in treatment of early stage hepatocellular carcinoma: resection versus liver transplantation.
Yi NJ; Suh KS; Kim T; Kim J; Shin WY; Lee KU
Oncology; 2008; 75 Suppl 1():124-8. PubMed ID: 19092282
[TBL] [Abstract][Full Text] [Related]
19. New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation?
Beaudreuil S; Samuel D; Rouas-Freiss N; Durrbach A
Transpl Immunol; 2007 Feb; 17(2):98-107. PubMed ID: 17306740
[TBL] [Abstract][Full Text] [Related]
20. Impact of immunosuppressants on host tissues and tolerance.
Calne R
Transplant Proc; 1994 Oct; 26(5):3065-70. PubMed ID: 7940964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
